Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
0.7782
Dollar change
-0.0898
Percentage change
-10.35
%
Index- P/E- EPS (ttm)-0.76 Insider Own25.46% Shs Outstand42.97M Perf Week6.71%
Market Cap33.63M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float32.21M Perf Month-1.24%
Income-30.28M PEG- EPS next Q- Inst Own16.37% Short Float7.32% Perf Quarter-22.18%
Sales0.00M P/S- EPS this Y- Inst Trans-17.73% Short Ratio21.28 Perf Half Y-35.42%
Book/sh1.72 P/B0.45 EPS next Y- ROA-23.97% Short Interest2.36M Perf Year-49.14%
Cash/sh1.57 P/C0.50 EPS next 5Y18.30% ROE-36.84% 52W Range0.63 - 1.70 Perf YTD-25.89%
Dividend Est.- P/FCF- EPS past 5Y-12.64% ROI-34.34% 52W High-54.22% Beta0.95
Dividend TTM- Quick Ratio7.16 Sales past 5Y0.00% Gross Margin- 52W Low22.92% ATR (14)0.06
Dividend Ex-Date- Current Ratio7.16 EPS Y/Y TTM38.03% Oper. Margin0.00% RSI (14)51.74 Volatility10.96% 8.10%
Employees32 Debt/Eq0.19 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price12.00
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q24.17% Payout- Rel Volume1.36 Prev Close0.87
Sales Surprise- EPS Surprise-81.95% Sales Q/Q- EarningsApr 01 BMO Avg Volume110.81K Price0.78
SMA208.59% SMA50-5.15% SMA200-24.97% Trades Volume150,233 Change-10.35%
Jun-26-24 07:13AM
Jun-25-24 07:00AM
Jun-04-24 07:15AM
Jun-03-24 07:00AM
May-13-24 01:53PM
07:00AM Loading…
07:00AM
May-06-24 04:05PM
Apr-02-24 09:53AM
Apr-01-24 07:00AM
Feb-22-24 07:00AM
Feb-15-24 07:00AM
Feb-07-24 04:05PM
Jan-04-24 04:05PM
Dec-04-23 07:21AM
Oct-23-23 07:00AM
04:05PM Loading…
Sep-28-23 04:05PM
Sep-06-23 07:00AM
Aug-15-23 10:20AM
Aug-10-23 04:05PM
Jul-24-23 07:00AM
Jul-13-23 08:00AM
Jun-06-23 08:00AM
Apr-11-23 07:00AM
Apr-06-23 04:05PM
Apr-05-23 04:05PM
Mar-22-23 05:00AM
Mar-21-23 08:00AM
Jan-30-23 04:05PM
Jan-27-23 08:00AM
Nov-21-22 09:09AM
08:00AM Loading…
Sep-16-22 08:00AM
Sep-12-22 08:00AM
Aug-30-22 04:05PM
Aug-25-22 04:05PM
Aug-04-22 08:00AM
Aug-01-22 08:00AM
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hannah BrendanCHIEF BUSINESS OFFICER AND COOJun 04 '24Option Exercise0.5556,06130,834257,616Jun 05 02:37 PM
Thye DirkCHIEF EXECUTIVE OFFICERJan 16 '24Option Exercise0.79240,530190,791689,441Jan 17 04:48 PM
Lamond DavidDirectorDec 14 '23Buy1.0422,62723,5322,347,545Dec 14 06:21 PM
Lamond DavidDirectorDec 13 '23Buy1.0022,62722,6272,324,918Dec 14 06:21 PM
Lamond DavidDirectorDec 12 '23Buy1.0222,32722,7742,302,291Dec 14 06:21 PM
Lamond DavidDirectorDec 12 '23Buy1.003003002,279,964Dec 14 06:21 PM
Lamond DavidDirectorDec 07 '23Buy1.0119,12319,3142,279,664Dec 07 06:30 PM
Lamond DavidDirectorDec 06 '23Buy1.0219,12319,5052,260,541Dec 07 06:30 PM
Lamond DavidDirectorDec 05 '23Buy1.0119,12319,3142,241,418Dec 07 06:30 PM
Lamond DavidDirectorDec 01 '23Buy0.9414,37813,5152,222,295Dec 01 01:38 PM
Lamond DavidDirectorNov 30 '23Buy0.9014,37812,9402,207,917Dec 01 01:38 PM
Lamond DavidDirectorNov 29 '23Buy0.9814,37814,0902,193,539Dec 01 01:38 PM
Lamond DavidDirectorAug 31 '23Buy1.3241,02654,1542,179,161Aug 31 06:42 PM
Lamond DavidDirectorAug 30 '23Buy1.3141,02653,7442,138,135Aug 31 06:42 PM
Lamond DavidDirectorAug 17 '23Buy1.2924,76631,9482,097,109Aug 17 06:08 PM
Lamond DavidDirectorAug 16 '23Buy1.29117,348151,3792,072,343Aug 17 06:08 PM
Lamond DavidDirectorAug 15 '23Buy1.32107,886142,4101,954,995Aug 17 06:08 PM
Thye DirkChief Executive OfficerAug 10 '23Buy1.2688,000110,880448,911Aug 11 04:15 PM
Thye DirkChief Executive OfficerAug 08 '23Buy1.2480,00099,200360,911Aug 09 06:23 PM
Hannah BrendanChief Business OfficerAug 08 '23Buy1.2271,76287,550201,555Aug 09 06:21 PM
McLoughlin MargaretDirectorAug 08 '23Buy1.238,0009,8408,000Aug 09 06:18 PM